CRISPR/Cas9 editing in human pluripotent stem cell-cardiomyocytes highlights arrhythmias, hypocontractility, and energy depletion as potential therapeutic targets for hypertrophic cardiomyopathy

Diogo Mosqueira, Ingra Mannhardt, Jamie R. Bhagwan, Katarzyna Lis-Slimak, Puspita Katili, Elizabeth Scott, Mustafa Hassan, Maksymilian Prondzynski, Stephen C. Harmer, Andrew Tinker, James G.W. Smith, Lucie Carrier, Philip M. Williams, Daniel Gaffney, Thomas Eschenhagen, Arne Hansen, Chris Denning

Research output: Contribution to journalArticlepeer-review

114 Citations (Scopus)
26 Downloads (Pure)

Search results